Skip to main content
. Author manuscript; available in PMC: 2022 Aug 13.
Published in final edited form as: ACS Infect Dis. 2021 Jun 11;7(8):2413–2424. doi: 10.1021/acsinfecdis.1c00158

Table 2.

Activities Against E. coli in the Presence of Specific Resistance Determinants (MIC, μg/mL)a

Resistance det WT-parental APH(3’)-Ia APH(3’)-IIa APH(3’)-IIb APH(3’)-VI AAC(3)-IV ArmA RmtB
Strain EC026 EC189 EC191 EC125 EC141 EC118 EC102 EC103
Propylamycin 1 0.25–0.5 64–128 0.5–1 0.5–1 0.5 1–2 0.5 0.5
Paromomycin 2 0.5–1 128 64 64–128 64 1–2 0.5–1 0.5–1
Lividomycin B 3 1–2 >128 1–2 0.5 1 2 1 1–2
8 0.5–1 2–4 1–2 0.5–1 0.5–1 2–4 2–4 2–4
9 0.5–1 4 1–2 0.5–1 0.5 2 1–2 2
10 1–2 8 4 4 1–2 8 4 4–8
11 0.5–1 2 0.5–1 0.5 0.25 2 2 4
12 1 8–16 2–4 2–4 0.5–1 16 8 4
13 0.5–1 2–4 1–2 0.5–1 0.5 4 4 2–4
14 1 >128 1–2 0.5–1 1 2–4 1 2
15 2 >32 4 4 1–2 16 4 4–8
a)

All values were determined in duplicate using twofold dilution series.